Trial Profile
The Utility of PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men With High GC Decipher Test Scores: A Sub-aim of the VANDAAM Study (MCC #18523)
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 30 Jun 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.
- 22 Mar 2022 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.
- 22 Mar 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Jun 2023.